GROUP ONE TRADING, L.P. - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is and the CUSIP is 86150R907. A total of 2 filers reported holding STOKE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,728
-85.7%
1,200
-61.3%
0.00%
Q2 2023$32,953
+97.8%
3,100
+55.0%
0.00%
Q1 2023$16,660
-60.8%
2,000
-56.5%
0.00%
Q4 2022$42,458
-86.2%
4,600
+91.7%
0.00%
-100.0%
Q3 2022$308,000
+34.5%
2,400
-59.3%
0.00%
Q1 2021$229,000
+2.7%
5,900
+63.9%
0.00%
Q4 2020$223,000
+1615.4%
3,600
+800.0%
0.00%
Q3 2020$13,000
-23.5%
400
-42.9%
0.00%
Q2 2020$17,0007000.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 400$13,0000.00%
SIMPLEX TRADING, LLC 19$63,0000.00%
View complete list of STOKE THERAPEUTICS INC shareholders